Search earnings tickers

REGN

2025Q3BMO

Regeneron Pharmaceuticals Inc primary · HEALTHCARE · BIOTECHNOLOGY

Report 2025-10-28 · Fiscal end 2025-09-30 · Features as of 2025-10-27

← Earnings history

Street

Consensus EPS9.64

Consensus rev—

EPS high—

EPS low—

Dispersion—

Analysts—

EPS rev net 7d—

EPS rev net 30d—

Consensus Δ 7d—

Consensus Δ 30d—

Options

Implied move2.2%

IV front—

P/C full—

P/C front—

Features as of2025-10-27

Run-up

Close—

Ret 5d+1.5%

Ret 10d+4.9%

Ret 20d+4.4%

Ret 30d+2.2%

Print

Actual EPS

11.83Beat

Estimated EPS9.64

Actual revenue

3.8B

Surprise %+22.7%

Beat / missBeat

Beat streak 42

Beat streak 82

Reaction

1-day stock reaction+6.9%

Implied vs actual

Implied 2.2%Actual 4.6%

Gap reaction+4.6%

Day result+11.8%

Next-day upYes

Realized / IV2.03×

Post tape

Post 5d-4.0%

Post 10d+3.1%

Post volume2.1M

Vol ×10d2.53×

Vol ×20d1.99×

Post range8.3%